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Abstract 
We report on a 22-year-old male patient who shows both classical Fabry 
disease and IgA nephropathy. He had proteinuria (1.5g/day), hypohidrosis, and 
neuralgia with fever. Serum creatinine and blood urea nitrogen were 0.9 mg/dl 
and 11.4 mg/dl, respectively. Renal biopsy showed strikingly vacuolated 
podocytes and tubular epithelium cells. Myelin-like bodies were detected in 
podocytes, mesangial cells, endothelial cells, and tubular epithelium cells by 
electron microscopy. On immunofluorescence microscopy, IgA and C3 deposits 
were detected in mesangial areas. From these results and a markedly low level 
of α-galactosidase A activity, we diagnosed this patient with classical Fabry 
disease and IgA nephropathy. 
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Introduction 
Fabry disease is a rare lysosomal storage disorder caused by a deficiency of α-
galactosidase A. The progressive accumulation of glycosphingolipids results in 
multiple organ insufficiency. One of the major clinical features is a renal 
manifestation, especially proteinuria and decreasing glomerular filtration rate. 
Because this disease is an X-linked disorder, heterozygous females show mild 
symptoms after lyonization of the abnormal X chromosome. On the other hand, 
IgA nephropathy is the most prevalent form of glomerulonephritis worldwide (1). 
Thus, the occurrence of Fabry heterozygous females with IgA nephropathy may 
be more frequent than predicted. But to our knowledge, there is no report of a 
hemizygous male with classical Fabry disease having IgA nephropathy. Here 
we report on a classical Fabry disease case in a hemizygous male patient that 
is coincident with IgA nephropathy. 
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Case report 
A 22-year-old male was referred to our hospital because of chance proteinuria. 
He showed proteinuria (1.5g/day), slight hematuria, and had experienced 
hypohidrosis and neuralgia with fever since he was 12 years old. The blood 
pressure was 118/72 mmHg. There was no edema. Serum creatinine and blood 
urea nitrogen were 0.9 mg/dl and 11.4 mg/dl, respectively. Hemoglobin was 
13.1 g/dl. Average creatinine clearance in three days was 121 ml/min. 
Immunoglobulin and complement levels were normal. His mother also showed 
proteinuria and neuralgia with fever, but she had received no previous 
assessment regarding her proteinuria. 
A renal biopsy was performed to examine the reason for the proteinuria. Three 
needle biopsy cores, including six glomeruli were submitted. One glomerular 
collapse with hyalinosis was oberved, and other glomeruli contained strikingly 
enlarged and vacuolated podocytes (Fig. 1a, b). Vacuolated changes were also 
observed in some tubular epithelium cells (Fig. 1a, b). Paramesangial deposits 
are shown stained with periodic acid methenamine silver (PAM)  (Fig. 1b). On 
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immunofluorescence microscopy, IgA and C3 deposits were detected in 
mesangial areas (Fig. 1c, d). Myelin-like bodies were detected in podocytes, 
mesangial cells, endothelial cells, and tubular epithelium cells by electron 
microscopy (Fig. 1e). Moreover, paramesangial electron-dense deposits were 
also observed (Fig. 1e). From the above renal biopsy results and a markedly 
low level of α-galactosidase A activity (0.12 nmol/hr/ml <6.0~10.8 nmol/hr/ml>), 
we diagnosed this patient with Fabry disease and IgA nephropathy.  After 
diagnosis, genetic study was performed (now in progress) and enzyme 
replacement therapy with recombinant α-galactosidase A (Fabrazyme 55mg by 
drip infusion once every 2 weeks), Temocapril 1 mg by oral administration and 
Dipyridamole 300 mg by oral administration were initiated. Recently, some 
reports show the importance of additional therapies with ACE inhibitors or 
angiotensin receptor blocker (2,3). In our case, we used ACE inhibitor. Since 
our patient’s blood pressure was low, we could not use high dose ACE inhibitor. 
He now attends our hospital for therapy. Three months after enzyme 
replacement therapy, blood GL-3 levels were decreased from 16.2mg/ml to 
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6.5mg/ml that was within normal limits, but the amount of proteinuria and renal 
function showed no change. 
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Discussion 
Fabry disease was described by Fabry and Anderson in 1898 (4). The 
frequency of this disease is about 1/40,000 to 1/60,000 in men (4), and the 
hemizygous males show more severe phenotype than heterozygous females. In 
this case report, we have demonstrated a classical hemizygous male case of 
Fabry disease with IgA nephropathy. The combination of classical Fabry 
disease and IgA nephropathy are very rare. But Recently, the involvements of 
immunopathologies in different sphingolipidoses have shown (5). Previously, 
three cases of the combination of Fabry disease and IgA nephropathy have 
been reported (6-8). Two of the three cases were heterozygous females. 
Kawamura et al reported on a 28-year-old male patient with both IgA 
nephropathy and Fabry disease (6). But this case was unusual, because the 
patient did not show any clinical manifestations apart from an abnormal 
urinalysis. To our knowledge, our case is the first report on IgA nephropathy in a 
hemizygous male with classical Fabry disease. Recently, Whybra et al reported 
on two adolescent sisters heterozygous for Fabry disease with 
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mesangioproliferative IgA nephropathy (9). In their report, the authors suggest 
that the combination of Fabry disease and IgA nephropathy is not merely 
coincidental. Furthermore, they described a correlation between aberrant 
glycosylation in the hinge region of IgA1 molecules and the production of 
circulating immune complexes (10). In our case, we could not observe the 
severe proliferation of mesangial cells in light microscopy, but dominant 
depositions of IgA in mesangial areas was seen in immunofluorescence 
microscopy. Aberrant glycosylation in the hinge region of IgA1 molecules is one 
of the pathogenesis of IgA nephropathy, but there is no definitive cause of 
aberrant glycosylation in the hinge region of IgA1. In our case, if we can 
observe the disappearance of IgA deposition in mesangial areas after enzyme 
replacemant therapy, the glycosphingolilisosis occurred by Fabry disease seem 
to be one of the reason of aberrant glycosylation in the hinge region of IgA1 
molecules. 
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legends for figures 
Figure (a): Light microscopy of kidney biopsy sample.  Vacuolated podocytes 
and tubular epithelium cells are observed (hematoxylin-eosin stain x400) (b): 
Paramesangial deposits are shown (periodic acid methenamine silver stain 
x400) (c), (d): Immunofluorescence of kidney biopsy sample. Deposits of IgA 
and C3 are shown in mesangial area. (e): Electron microscopy of kidney biopsy 
sample. Myelin-like bodies are present in podocytes [P], mesangial cells, 
endothelial cells [E], and tubular epithelium cells. Paramesangial electron-dense 
deposit are also observed in the mesangial area (arrow). 
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